Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Felbamate

¹College of Pharmacy, University of Minnesota, Minneapolis 55415.

The Annals of Pharmacotherapy

|September 1, 1993

Summary

This summary is machine-generated.

Felbamate (FBM) is an effective antiepileptic medication for complex partial seizures and Lennox-Gastaut syndrome. While generally well-tolerated, further research is needed for specific patient populations.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Management of seizures in brain tumor patients at the end of life.

Journal of palliative medicine·2005

Same author

Variability of total phenytoin serum concentrations within elderly nursing home residents.

Neurology·2003

Same author

The new generation of antiepileptic drugs: unresolved questions.

The Annals of pharmacotherapy·1998

Same author

Population pharmacokinetics of carbamazepine in adults with epilepsy.

Pharmacotherapy·1998

Same author

A randomized double-blind study of carbamazepine in the treatment of cocaine abuse.

Clinical pharmacology and therapeutics·1997

Same author

Current developments in neurology, Part II: Advances in the pharmacotherapy of Alzheimer disease, Parkinson's disease, and stroke.

The Annals of pharmacotherapy·1996

Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026

Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026

Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026

Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026

Same journal

Modified vs Full Lead-in Dose Apixaban and Rivaroxaban for Treatment of Acute Venous Thromboembolism.

The Annals of pharmacotherapy·2026

Same journal

A Comparison of Phenobarbital Dosing Strategies for the Treatment of Alcohol Withdrawal Syndrome.

The Annals of pharmacotherapy·2026

See all related articles

Area of Science:

Neurology
Pharmacology

Background:

Epilepsy management requires effective antiepileptic medications.
Felbamate (FBM) emerged as a potential treatment option.

Purpose of the Study:

To review the current literature on felbamate (FBM).
To assess its efficacy and safety as an antiepileptic medication (AEM).

Main Methods:

Comprehensive literature search of published manuscripts and abstracts up to January 1993.
Information abstraction and organization by the author.

Main Results:

Felbamate (FBM) demonstrates efficacy in complex partial seizures, as monotherapy or adjunct.
It is also effective for seizures associated with Lennox-Gastaut syndrome.

Adverse effects are generally mild, with insomnia and weight loss noted in monotherapy.

Conclusions:

Felbamate (FBM) is a promising new antiepileptic medication.
Further studies are required for its use in newly diagnosed epilepsy, pregnant patients, children, and those with renal failure or on non-epilepsy drugs.